SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

79,310.01 2,008.61
( 2.60%)

Global Indices

Nasdaq

53,347.89 1,540.17
(2.97%)

Dow Jones

7,717.41 127.49
(1.68%)

Hang Seng

60,935.13 -1,253.50
(-2.02%)

Nikkei 225

10,776.27 -52.94
(-0.49%)

Forex

USD-INR

94.73 -0.07
(-0.07%)

EUR-INR

105.99 -0.12
(-0.11%)

GBP-INR

127.06 -0.04
(-0.03%)

JPY-INR

0.60 0.00
(-0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Lyka Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500259

INE933A01014

25.0090266

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LYKALABS

274.76

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	120.91	134.70	106.40	80.59	164.35	62.26
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	120.91	134.70	106.40	80.59	164.35	62.26
Other Income	3.97	2.76	1.65	3.45	2.72	2.21
Stock Adjustments	1.08	1.37	0.79	1.21	0.40	-2.04
Total Income	125.96	138.83	108.84	85.25	167.47	62.43
EXPENDITURE :
Raw Materials	46.57	54.60	43.73	30.27	31.27	21.48
Power & Fuel Cost	4.24	3.90	3.92	3.57	3.88	2.91
Employee Cost	41.60	34.40	26.01	17.48	16.22	13.03
Other Manufacturing Expenses	4.92	5.22	4.49	2.81	2.25	2.27
Selling & Administrative Expenses	19.17	19.09	13.20	11.18	12.04	5.63
Miscellaneous Expenses	30.90	1.46	1.33	8.06	6.26	1.91
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	147.40	118.66	92.68	73.37	71.93	47.22
Operating Profit	-21.45	20.17	16.15	11.88	95.55	15.20
Interest	3.33	2.30	4.80	11.57	19.92	25.55
Gross Profit	-24.78	17.87	11.35	0.31	75.63	-10.35
Depreciation	8.46	6.77	12.29	13.52	15.39	8.05
Profit Before Tax	-33.24	11.10	-0.94	-13.21	60.24	-18.40
Tax	0.83	2.73	1.60	0.21	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-1.77	0.46	-0.26	-0.13	20.34	-3.94
Reported Net Profit	-32.29	7.92	-2.27	-13.29	39.90	-14.46
Extraordinary Items	-23.01	0.03	0.04	-7.06	-3.09	-1.43
Adjusted Net Profit	-9.28	7.89	-2.31	-6.23	42.99	-13.03
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	-112.42	-120.33	-101.38	-88.09	-127.99	-113.54
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-144.70	-112.42	-103.65	-101.38	-88.09	-127.99
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-9.05	2.22	-0.69	-4.33	13.91	-5.04
Earnings Per Share(Adj)-Unit Curr	-9.05	2.22	-0.69	-4.33	13.91	-5.04
Book Value-Unit Curr	24.38	34.07	27.28	19.22	15.49	1.54
Book Value(Adj)-Unit Curr	24.38	34.07	27.28	19.22	15.49	1.54

79,310.01 2,008.61 ( 2.60%)

53,347.89 1,540.17 (2.97%)

7,717.41 127.49 (1.68%)

60,935.13 -1,253.50 (-2.02%)

10,776.27 -52.94 (-0.49%)

94.73 -0.07 (-0.07%)

105.99 -0.12 (-0.11%)

127.06 -0.04 (-0.03%)

0.60 0.00 (-0.31%)